Holding the Pharmacy to the Same Standards as the Contract Micro Lab

When a Pharmacy Becomes a “Micro Lab”

Pharmacies that incubate samples, read plates, or conduct viable environmental monitoring are effectively operating as small microbiology labs—even if they do not formally identify themselves that way.

This shift brings expanded responsibilities, including:

• Proper incubation practices
• Accurate plate reading
• Sample handling integrity
• Microbiological interpretation

The message is clear: once you take on these activities, expectations change.

Regulatory Scrutiny and Inspection Risk

Taking environmental monitoring and incubation in-house invites additional regulatory scrutiny.

Inspectors and surveyors will:

• Be curious about laboratory practices
• Evaluate compliance with applicable standards
• Assess whether proper controls and documentation are in place

Pharmacies must anticipate increased oversight and be prepared to defend their processes.

Setting Expectations: What You Would Demand from a Contract Lab

The speaker encourages participants to reflect on what they would expect if outsourcing to a contract micro lab:

• Formal training and credentialing
• Established standard operating procedures
• Documented processes
• Quality systems and oversight

The key takeaway is consistency: pharmacies should hold themselves to the same standards they would demand from an external laboratory partner.

Training, Credentials, and Competency Requirements

Training is identified as a foundational element of defensible lab operations.

Considerations include:

• Documented training programs
• Demonstrated competency
• Ongoing qualification
• Clear delineation of responsibilities

If pharmacy personnel are performing microbiological tasks, they must be appropriately trained and qualified to do so.

Standard Operating Procedures (SOPs) and Documentation

SOPs are essential when operating an in-house micro program. Pharmacies must develop written procedures covering:

• Sample collection
• Incubation parameters
• Plate reading methodology
• Documentation and record retention
• Corrective action processes

Without robust documentation, compliance and defensibility during inspection are compromised.

USP Resources and Regulatory Framework

The speaker highlights key USP chapters relevant to in-house microbiological operations:

• USP <797> – Foundational sterile compounding requirements
• USP <1116> – Microbiological control and monitoring (more manufacturing-focused)
• USP <1117> – Microbiological best laboratory practices

USP <1117> is emphasized as particularly important because it addresses laboratory practices directly.

Pharmacies are encouraged to ensure access to the full USP compendium, as certain chapters are not included in abbreviated versions.

Additional guidance documents, such as industry application guides related to viable environmental monitoring, are also noted as helpful resources.

Building a Sustainable and Defensible In-House Micro Program

The overall message is cautionary but constructive: taking environmental monitoring and incubation in-house is possible, but it requires:

• Regulatory awareness
• Structured documentation
• Qualified personnel
• Defined quality systems
• Inspection readiness

Pharmacies must recognize that they are assuming laboratory-level responsibilities and must operate accordingly to maintain compliance and patient safety.